Related Experiment Video

Updated: Aug 12, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Neonatal hypoglycemia. Back to basics in diagnosis and treatment

R Schwartz1

  • 1Division of Biology and Medicine, Brown University, Providence, Rhode Island.

Diabetes
|December 1, 1991
PubMed

Insights

Hypoglycemia in infants of diabetic mothers is common, but long-term neurodevelopmental issues are not typically observed. Current diagnostic criteria for blood glucose levels are inconsistent and may not be reliable.

Area of Science:

  • Neonatal care
  • Endocrinology
  • Pediatric neurology

Background:

  • Infants of diabetic mothers (IDMs) are at risk for hypoglycemia.
  • The long-term neurodevelopmental and behavioral significance of neonatal hypoglycemia in IDMs is not well-defined.
  • Previous follow-up studies have generally not identified persistent central nervous system (CNS) problems.

Purpose of the Study:

  • To review the current understanding of hypoglycemia in infants of diabetic mothers.
  • To evaluate the long-term neurodevelopmental and behavioral outcomes associated with this condition.
  • To discuss the evolving diagnostic criteria for neonatal hypoglycemia.

Main Methods:

  • Literature review of studies on infants of diabetic mothers and neonatal hypoglycemia.
  • Analysis of follow-up data regarding neurodevelopment and behavior.
  • Examination of the evolution of diagnostic criteria for hypoglycemia.

Main Results:

  • Most follow-up studies do not report significant long-term CNS problems in infants with neonatal hypoglycemia.
  • Diagnostic criteria for hypoglycemia have shifted towards adult levels.
  • A single, universally dependable criterion for diagnosing hypoglycemia is lacking.

Conclusions:

  • While hypoglycemia is frequently observed in infants of diabetic mothers, its long-term impact on neurodevelopment and behavior appears minimal based on current literature.
  • The diagnostic criteria for neonatal hypoglycemia require careful consideration due to their evolving nature and lack of universal standardization.
  • Further research may be needed to establish definitive diagnostic thresholds and understand any subtle long-term effects.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...